Journal
OZONE-SCIENCE & ENGINEERING
Volume 33, Issue 4, Pages 253-266Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/01919512.2011.578038
Keywords
Ozone; Pharmaceuticals; Endocrine-Disrupting Compounds (EDCs); Pilot-Scale; Full-Scale; Toxicity; Water Reuse
Categories
Funding
- WateReuse Research Foundation [WRF-08-05, WRF-09-10]
Ask authors/readers for more resources
Increased public awareness, potential human health effects, and demonstrated impacts on aquatic ecosystems have stimulated recent interest in pharmaceuticals, personal care products (PPCPs), and endocrine-disrupting compounds (EDCs) in water and wastewater. Due to the potential public and environmental health implications, some agencies are taking a proactive approach to controlling trace organic contaminant (TOrC) concentrations in water supplies. This review describes some of the research related to the toxicity and estrogenicity of wastewater-derived TOrCs in addition to regulatory guidance from several international agencies. This review also evaluates pilot- and full-scale studies to characterize the efficacy of ozonation for TOrC mitigation in wastewater applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available